ATLAS: A positive, high-yield review of patient symptoms most significantly associated with melanoma recurrence
Any treating physician using this model may have a greater opportunity to detect recurrent cutaneous melanoma and improve outcomes while limiting cost and morbidity.
Authors
- D MCDANIEL
- Hensin Tsao (ORCID: https://orcid.org/0000-0002-2204-2071)
- Gabriel E. Molina (ORCID: https://orcid.org/0000-0002-2608-6629)
- Ziyou Ren (ORCID: https://orcid.org/0000-0001-7127-4197)
- Emily Everdell (ORCID: https://orcid.org/0000-0001-5740-7205)
- Alana Deutsch (ORCID: https://orcid.org/0000-0002-8072-7693)
- Justine V. Cohen (ORCID: https://orcid.org/0000-0003-4803-9230)
- Jenna Borok (ORCID: https://orcid.org/0000-0001-5692-1990)
- Sitaram Vangala
Institutions
- Northwestern University (US)
- University of California, Los Angeles (US)
- Yale University (US)
- Massachusetts General Hospital (US)
- Dana-Farber Cancer Institute (US)
- Stanford University (US)
Publication Details
- Journal
- Journal of the American Academy of Dermatology
- Published
- 2024-08-26
- DOI
- https://doi.org/10.1016/j.jaad.2024.07.1516
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00